Sanofi Pasteur, the world's largest vaccines company, and China's prestigious Xiamen University have agreed to jointly research the development of a universal flu vaccine. According to an agreement signed on Wednesday, Sanofi Pasteur will fund research on broad-spectrum neutralization monoclonal antibodies to treat the influenza virus, work which is already being carried out by the National Institute of Diagnostics and Vaccine Development in Infectious Diseases (NIDVD) under Xiamen University. It is hoped that the cooperation will prompt the development of a universal flu vaccine, a vaccine that doesn't require updating each year. Zhu Chongshi, principal of Xiamen University, labeled the joint program a pioneering effort that will benefit mankind. Sanofi Pasteur provided more than 200 million doses of seasonal influenza vaccines in 2012, accounting for about 40 percent of global market share. Founded in 2005, the NIDVD is the only national institute of its kind in China. It aims to develop original and innovative diagnostic tests and vaccines, and to industrialize them through collaboration with academia, industry and the healthcare sector. Influenza is a contagious virus that mainly spreads through coughing. About 250,000 to 500,000 people die from the virus each year worldwide, according to the World Health Organization.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor